Patrick Trucchio
Stock Analyst at HC Wainwright & Co.
(4.2)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
ASMB Assembly Biosciences | Assumes: Buy | 50 | 23.2 | 115.52% | 1 | Aug 18, 2025 | |
ALT Altimmune | Reiterates: Buy | 12 12 | 3.75 | 220% | 19 | Aug 13, 2025 | |
ALNY Alnylam Pharmaceutic... | Maintains: Strong Buy | 500 570 | 475.02 | 19.99% | 27 | Aug 7, 2025 | |
CMPS Compass Pathways | Maintains: Buy | 45 40 | 5.09 | 685.85% | 17 | Aug 4, 2025 | |
ATAI ATAI Life Sciences | Maintains: Strong Buy | 10 15 | 4.76 | 215.13% | 20 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 3.71 | 169.54% | 2 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 1.15 | 334.78% | 19 | Jun 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 0.51 | 1860.78% | 26 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 75 75 | 5.26 | 1325.86% | 24 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 100 100 | 36.42 | 174.57% | 21 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 70 70 | 17.15 | 308.16% | 15 | May 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 5 | 1.38 | 262.32% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 60 60 | 5.11 | 1074.17% | 18 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 27.49 | 191.01% | 23 | May 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 40 40 | 13.39 | 198.73% | 15 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 30 30 | 3.93 | 663.36% | 10 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 70 70 | 33.6 | 108.33% | 6 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 80 80 | 19.8 | 304.04% | 8 | Apr 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 25 10 | 1.72 | 481.4% | 19 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 2.75 | 263.64% | 16 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 55 55 | 9.54 | 476.52% | 18 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 110 110 | 5.2 | 2015.38% | 23 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 85 85 | 40.25 | 111.18% | 2 | Feb 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 190 150 | 6.36 | 2258.49% | 17 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 80 60 | n/a | n/a | 14 | Oct 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 15 7 | 6.49 | 0.15% | 8 | Nov 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 360 | 0.93 | 38609.68% | 5 | May 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 5 | n/a | n/a | 2 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 20 | 1.12 | 1685.71% | 1 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 3 | n/a | n/a | 2 | Feb 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 5 | n/a | n/a | 1 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 170 68 | 13.99 | 386.06% | 2 | Sep 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 35 7 | 7.12 | -1.69% | 4 | Jul 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 120 100 | 99.99 | 0.01% | 3 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 230 20 | n/a | n/a | 2 | Dec 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 500 625 | n/a | n/a | 2 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 25 10 | n/a | n/a | 3 | Oct 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 260 340 | 192.24 | 76.86% | 1 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 8 | n/a | n/a | 1 | Jul 26, 2021 |